Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates?

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 101, Issue 3, 2006, Pages

  Dohan, David M ^a,b,j   Choukroun, Joseph ^c   Diss, Antoine ^d,e   Dohan, Steve L ^a,b   Dohan, Anthony J J ^f   Mouhyi, Jaafar ^g,h,i   Gogly, Bruno ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hopital Albert Chenevier   (France)

^c Pain Clinic Center   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

^e University Hospital of Nice University of Nice Sophia Antipolis   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g University of Southern California ^*

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

^j Biophysics Laboratory   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33644544784     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2005.07.010     Document Type: Article

References (37)

1. R.E. Marx, E.R. Carlson, R.M. Eichstaedt, S.R. Schimmele, J.E. Strauss, and K.R. Georgeff Platelet-rich plasma: growth factor enhancement for bone grafts Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 1998 638 646
2. E. Soffer, J.P. Ouhayoun, and F. Anagnostou Fibrin sealants and platelet preparations in bone and periodontal healing Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 2003 521 528
3. D. Dohan, J.-M. Donsimoni, G. Navarro, and F. Gaultier [Platelet concentrates. Part 1: Technologies.] Implantodontie 12 2003 5 16 French
4. D. Dohan, J.-M. Donsimoni, G. Navarro, and F. Gaultier [Platelet concentrates. Part 2: Associated biology.] Implantodontie 12 2003 17 25 French
5. F. Gaultier, G. Navarro, J.-M. Donsimoni, and D. Dohan [Platelet concentrates. Part 3: Clinical applications.] Implantodontie 13 2004 3 11 French
6. A. Simonpieri, J. Choukroun, M.O. Girard, T. Ouaknine, and D. Dohan [Immediate post-extraction implantation: interest of the PRF.] Implantodontie 13 2004 177 189 French
7. W.V. Giannobile Periodontal tissue engineering by growth factors Bone 19 1 Suppl 1996 23S 37S
8. G. Weibrich, W.K. Kleis, M. Kunz-Kostomanolakis, A.H. Loos, and W. Wagner Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor Int J Oral Maxillofac Implants 16 2001 693 699
9. G. Weibrich, W.K. Kleis, R. Buch, W.E. Hitzler, and G. Hafner The Harvest SmartPReP system versus the Friadent-Schutze platelet-rich plasma kit Clin Oral Implants Res 14 2003 233 239
10. G. Weibrich, W.K. Kleis, G. Hafner, W.E. Hitzler, and W. Wagner Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank Clin Oral Implants Res 14 2003 357 362
11. C.A. Dinarello The IL-1 family and inflammatory diseases Clin Exp Rheumatol 20 5 Suppl 27 2002 S1 S13
12. L.J. Rosenwasser Biologic activities of IL-1 and its role in human disease J Allergy Clin Immunol 102 1998 344 350
13. C.A. Dinarello Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation Curr Opin Pharmacol 4 2004 378 385
14. S. Kwan Tat, M. Padrines, S. Theoleyre, D. Heymann, and Y. Fortun IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology Cytokine Growth Factor Rev 15 2004 49 60
15. A.M. Tiggelman, W. Boers, C. Linthorst, H.S. Brand, M. Sala, and R.A. Chamuleau Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha J Hepatol 23 1995 295 306
16. D. Kamimura, K. Ishihara, and T. Hirano IL-6 signal transduction and its physiological roles: the signal orchestration model Rev Physiol Biochem Pharmacol 149 2003 1 38
17. P.C. Heinrich, I. Behrmann, S. Haan, H.M. Hermanns, G. Muller-Newen, and F. Schaper Principles of interleukin (IL)-6-type cytokine signaling and its regulation Biochem J 374 Pt 1 2003 1 20
18. N. Nishimoto, and T. Kishimoto Inhibition of IL-6 for the treatment of inflammatory diseases Curr Opin Pharmacol 4 2004 386 391
19. B.B. Aggarwal, S. Shishodia, K. Ashikawa, and A.C. Bharti The role of TNF and its family members in inflammation and cancer: lessons from gene deletion Curr Drug Targets Inflamm Allergy 1 2002 327 341
20. B.B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol 3 2003 745 756
21. U. Gaur, and B.B. Aggarwal Regulation of proliferation, survival and apoptosis by members of the TNF superfamily Biochem Pharmacol 66 2003 1403 1408
22. M. Boothby, A.L. Mora, M.A. Aronica, J. Youn, J.R. Sheller, S. Goenka, and L. Stephenson IL-4 signaling, gene transcription regulation, and the control of effector T cells Immunol Res 23 2001 179 191
23. A.D. Keegan, and J. Zamorano Regulation of gene expression, growth, and cell survival by IL-4: contribution of multiple signaling pathways Cell Res 8 1998 1 13
24. N.E. Kay, and B.T. Pittner IL-4 biology: impact on normal and leukemic CLL B cells Leuk Lymphoma 44 2003 897 903
25. A.M. Tiggelman, W. Boers, C. Linthorst, M. Sala, and R.A. Chamuleau Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma J Hepatol 23 1995 307 317
26. Y. Hayashi, M. Kobayashi, H. Kuwata, G. Atsumi, K. Deguchi, and X. Feng Wei Interferon-gamma and interleukin 4 inhibit interleukin 1beta-induced delayed prostaglandin E(2)generation through suppression of cyclooxygenase-2 expression in human fibroblasts Cytokine 12 2000 603 612
27. M. Li-Weber, O. Laur, I. Davydov, C. Hu, P. Salgame, and P.H. Krammer What controls tissue-specific expression of the IL-4 gene? Immunobiology 198 1997 170 178
28. M.A. Brown, and J. Hural Functions of IL-4 and control of its expression Crit Rev Immunol 17 1997 1 32
29. I. Zachary VEGF signalling: integration and multi-tasking in endothelial cell biology Biochem Soc Trans 31 Pt 6 2003 1171 1177
30. L.E. Harry, and E.M. Paleolog From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis Birth Defects Res Part C Embryo Today 69 2003 363 374
31. C. Ruhrberg Growing and shaping the vascular tree: multiple roles for VEGF Bioessays 25 2003 1052 1060
32. A. Tiong, and S.B. Freedman Gene therapy for cardiovascular disease: the potential of VEGF Curr Opin Mol Ther 6 2004 151 159
33. J. Choukroun, F. Adda, C. Schoeffler, and A. Vervelle Une opportunité en paro-implantologie: le PRF Implantodontie 42 2001 55 62 French
34. T.R. Appel, B. Potzsch, J. Muller, J.J. von Lindern, S.J. Berge, and R.H. Reich Comparison of 3 different preparations of platelet concentrates for growth factor enrichment Clin Oral Implants Res 13 2002 522 528
35. G. Weibrich, W.K. Kleis, and G. Hafner Growth factor levels in the platelet-rich plasma produced by 2 different methods: Curasan-type PRP kit versus PCCS PRP system Int J Oral Maxillofac Implants 17 2002 184 190
36. G. Weibrich, W.K. Kleis, G. Hafner, and W.E. Hitzler Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count J Craniomaxillofac Surg 30 2002 97 102
37. R. Zimmermann, R. Jakubietz, M. Jakubietz, E. Strasser, A. Schlegel, J. Wiltfang, and R. Eckstein Different preparation methods to obtain platelet components as a source of growth factors for local application Transfusion 41 2001 1217 1224